C. Aufricht et al., IRON SUPPLEMENTATION IN CHILDREN AFTER CARDIOPULMONARY BYPASS FOR SURGICAL REPAIR OF CONGENITAL HEART-DISEASE, Pediatric cardiology, 15(4), 1994, pp. 167-169
A controlled study was carried out to evaluate the effects of postoper
ative iron therapy on iron status in anemic children after cardiopulmo
nary bypass. The patients were 8 boys and 9 girls (mean age 6.5 years)
who underwent elective closure of atrial septal defect, secundum type
. On postoperative day 9, patients were randomly assigned to either ir
on supplementation with iron sulfate 5 mg/kg until day 56 or to a cont
rol group. Hemoglobin, reticulocytes, transferrin saturation, free ery
throcyte protoporphyrin, and ferritin were measured, the final outcome
measure being postoperative iron status on day 56. The treatment grou
p showed higher transferrin saturations (33.5% versus 18.0%), smaller
decreases in ferritin level (+ 3.0 versus - 13.7 ng/ml), and a lower i
ncidence of depleted iron stores (0/8 versus 5/9) than the control gro
up (all data: P < 0.05). Anemic children after cardiopulmonary bypass
for surgical repair of congenital heart disease thus benefit from iron
supplementation within the first postoperative weeks.